Burcon NutraScience Corporation (TSX:BU)
Canada · Delayed Price · Currency is CAD 1.800
-0.050 (-2.70%)
Aug 18, 2026, 11:16 AM EST
Burcon NutraScience Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3.2 | 2.26 | 0.38 | 0.18 | 0.36 | 0.17 | |
Revenue Growth | 556.85% | 493.78% | 106.88% | -49.34% | 112.23% | -33.70% |
Cost of Revenue | 11.22 | 9.7 | 1.25 | - | - | - |
Gross Profit | -8.02 | -7.44 | -0.87 | 0.18 | 0.36 | 0.17 |
Selling, General & Admin | 3.1 | 3.02 | 3.9 | 3.74 | 3.94 | 4.53 |
Research & Development | 0.93 | 0.92 | 2.92 | 3.46 | 3.95 | 3.38 |
Operating Expenses | 4.02 | 3.94 | 6.83 | 7.2 | 7.89 | 7.91 |
Operating Income | -12.05 | -11.38 | -7.7 | -7.02 | -7.53 | -7.74 |
Interest Expense | -3.64 | -3.23 | -0.63 | -0.41 | -0.2 | -0.06 |
Interest & Investment Income | 0.11 | 0.14 | 0.08 | 0.09 | 0.41 | 0.41 |
Earnings From Equity Investments | - | - | - | - | -5.5 | -4.29 |
Currency Exchange Gain (Loss) | 0.41 | -0.12 | 0.02 | -0 | 0 | -0 |
Other Non Operating Income (Expenses) | 0.02 | -0.06 | -0.03 | -0.1 | -0.27 | 0.11 |
EBT Excluding Unusual Items | -15.15 | -14.64 | -8.26 | -7.45 | -13.08 | -11.59 |
Gain (Loss) on Sale of Investments | - | - | - | - | -7.99 | 0.96 |
Other Unusual Items | - | - | - | - | -4.36 | 0.34 |
Pretax Income | -15.15 | -14.64 | -8.26 | -7.45 | -25.42 | -10.29 |
Income Tax Expense | -0.6 | -0.39 | - | - | -0.06 | -0.03 |
Net Income | -14.55 | -14.25 | -8.26 | -7.45 | -25.36 | -10.26 |
Net Income to Common | -14.55 | -14.25 | -8.26 | -7.45 | -25.36 | -10.26 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 13 | 13 | 8 | 6 | 5 | 5 |
Shares Outstanding (Diluted) | 13 | 13 | 8 | 6 | 5 | 5 |
Shares Change | 36.25% | 62.77% | 28.83% | 11.65% | 0.13% | 5.54% |
EPS (Basic) | -1.15 | -1.12 | -1.06 | -1.23 | -4.67 | -1.89 |
EPS (Diluted) | -1.16 | -1.13 | -1.06 | -1.23 | -4.67 | -1.89 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -9.73 | -10.12 | -5.82 | -5.9 | -6.38 | -5.97 |
Free Cash Flow Per Share | -0.77 | -0.80 | -0.74 | -0.97 | -1.17 | -1.10 |
Gross Margin | -250.79% | - | -228.31% | 100.00% | 100.00% | 100.00% |
Operating Margin | -376.60% | -502.33% | -2018.75% | -3807.23% | -2067.88% | -4512.57% |
Profit Margin | -455.02% | -629.38% | -2166.98% | -4038.96% | -6969.87% | -5982.59% |
Free Cash Flow Margin | -304.16% | -446.86% | -1525.02% | -3202.50% | -1751.91% | -3478.73% |
EBITDA | -10.98 | -11.11 | -7.43 | -6.8 | -7.29 | -7.58 |
D&A For EBITDA | 1.06 | 0.26 | 0.26 | 0.22 | 0.24 | 0.16 |
EBIT | -12.05 | -11.38 | -7.7 | -7.02 | -7.53 | -7.74 |